Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ABMD's Cash to Debt is ranked higher than
98% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. ABMD: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ABMD' s 10-Year Cash to Debt Range
Min: 382.22  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.86
ABMD's Equity to Asset is ranked higher than
87% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. ABMD: 0.86 )
Ranked among companies with meaningful Equity to Asset only.
ABMD' s 10-Year Equity to Asset Range
Min: 0.79  Med: 0.86 Max: 0.93
Current: 0.86
0.79
0.93
Interest Coverage No Debt
ABMD's Interest Coverage is ranked higher than
98% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. ABMD: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ABMD' s 10-Year Interest Coverage Range
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 7
Z-Score: 40.14
M-Score: -1.23
WACC vs ROIC
8.13%
114.23%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 12.45
ABMD's Operating margin (%) is ranked higher than
77% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. ABMD: 12.45 )
Ranked among companies with meaningful Operating margin (%) only.
ABMD' s 10-Year Operating margin (%) Range
Min: -111.48  Med: -32.51 Max: 12.45
Current: 12.45
-111.48
12.45
Net-margin (%) 49.36
ABMD's Net-margin (%) is ranked higher than
99% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. ABMD: 49.36 )
Ranked among companies with meaningful Net-margin (%) only.
ABMD' s 10-Year Net-margin (%) Range
Min: -84.54  Med: -26.26 Max: 49.36
Current: 49.36
-84.54
49.36
ROE (%) 56.76
ABMD's ROE (%) is ranked higher than
99% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.14 vs. ABMD: 56.76 )
Ranked among companies with meaningful ROE (%) only.
ABMD' s 10-Year ROE (%) Range
Min: -46.87  Med: -16.23 Max: 49.44
Current: 56.76
-46.87
49.44
ROA (%) 47.12
ABMD's ROA (%) is ranked higher than
99% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.22 vs. ABMD: 47.12 )
Ranked among companies with meaningful ROA (%) only.
ABMD' s 10-Year ROA (%) Range
Min: -42.19  Med: -14.33 Max: 41.81
Current: 47.12
-42.19
41.81
ROC (Joel Greenblatt) (%) 104.63
ABMD's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. ABMD: 104.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ABMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -294.77  Med: -104.30 Max: 90.23
Current: 104.63
-294.77
90.23
Revenue Growth (3Y)(%) 19.50
ABMD's Revenue Growth (3Y)(%) is ranked higher than
88% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. ABMD: 19.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ABMD' s 10-Year Revenue Growth (3Y)(%) Range
Min: -7.2  Med: 10.80 Max: 19.5
Current: 19.5
-7.2
19.5
EBITDA Growth (3Y)(%) 69.50
ABMD's EBITDA Growth (3Y)(%) is ranked higher than
96% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. ABMD: 69.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ABMD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -56.2  Med: 11.45 Max: 133.8
Current: 69.5
-56.2
133.8
EPS Growth (3Y)(%) 304.60
ABMD's EPS Growth (3Y)(%) is ranked higher than
98% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. ABMD: 304.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ABMD' s 10-Year EPS Growth (3Y)(%) Range
Min: -52.4  Med: 11.75 Max: 304.6
Current: 304.6
-52.4
304.6
» ABMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

ABMD Guru Trades in Q2 2014

Jim Simons 97,223 sh (New)
Chase Coleman 1,690,000 sh (New)
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
PRIMECAP Management 5,726,490 sh (-0.44%)
» More
Q3 2014

ABMD Guru Trades in Q3 2014

Chase Coleman 1,690,000 sh (unchged)
Jim Simons Sold Out
PRIMECAP Management 5,664,990 sh (-1.07%)
» More
Q4 2014

ABMD Guru Trades in Q4 2014

Joel Greenblatt 22,440 sh (New)
PRIMECAP Management 5,687,590 sh (+0.40%)
Chase Coleman Sold Out
» More
Q1 2015

ABMD Guru Trades in Q1 2015

Paul Tudor Jones 12,243 sh (New)
Jim Simons 188,263 sh (New)
Joel Greenblatt 22,429 sh (-0.05%)
PRIMECAP Management 5,662,590 sh (-0.44%)
» More
» Details

Insider Trades

Latest Guru Trades with ABMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 30.22
ABMD's P/E(ttm) is ranked lower than
51% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 28.40 vs. ABMD: 30.22 )
Ranked among companies with meaningful P/E(ttm) only.
ABMD' s 10-Year P/E(ttm) Range
Min: 23.17  Med: 97.10 Max: 946.92
Current: 30.22
23.17
946.92
Forward P/E 172.41
ABMD's Forward P/E is ranked lower than
95% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.26 vs. ABMD: 172.41 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 28.30
ABMD's PE(NRI) is ranked higher than
50% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 28.30 vs. ABMD: 28.30 )
Ranked among companies with meaningful PE(NRI) only.
ABMD' s 10-Year PE(NRI) Range
Min: 23.15  Med: 96.51 Max: 820.67
Current: 28.3
23.15
820.67
P/B 11.01
ABMD's P/B is ranked lower than
90% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. ABMD: 11.01 )
Ranked among companies with meaningful P/B only.
ABMD' s 10-Year P/B Range
Min: 1.58  Med: 4.77 Max: 12.69
Current: 11.01
1.58
12.69
P/S 14.37
ABMD's P/S is ranked lower than
84% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. ABMD: 14.37 )
Ranked among companies with meaningful P/S only.
ABMD' s 10-Year P/S Range
Min: 2.38  Med: 6.10 Max: 14.03
Current: 14.37
2.38
14.03
PFCF 88.29
ABMD's PFCF is ranked lower than
84% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 30.88 vs. ABMD: 88.29 )
Ranked among companies with meaningful PFCF only.
ABMD' s 10-Year PFCF Range
Min: 23.56  Med: 50.34 Max: 2462
Current: 88.29
23.56
2462
POCF 77.68
ABMD's POCF is ranked lower than
87% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 21.63 vs. ABMD: 77.68 )
Ranked among companies with meaningful POCF only.
ABMD' s 10-Year POCF Range
Min: 21.88  Med: 48.61 Max: 463.25
Current: 77.68
21.88
463.25
EV-to-EBIT 108.50
ABMD's EV-to-EBIT is ranked lower than
94% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 21.84 vs. ABMD: 108.50 )
Ranked among companies with meaningful EV-to-EBIT only.
ABMD' s 10-Year EV-to-EBIT Range
Min: -305.5  Med: -10.20 Max: 694.7
Current: 108.5
-305.5
694.7
Shiller P/E 205.72
ABMD's Shiller P/E is ranked lower than
94% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 30.75 vs. ABMD: 205.72 )
Ranked among companies with meaningful Shiller P/E only.
ABMD' s 10-Year Shiller P/E Range
Min: 157.16  Med: 177.08 Max: 201.2
Current: 205.72
157.16
201.2
Current Ratio 5.60
ABMD's Current Ratio is ranked higher than
78% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. ABMD: 5.60 )
Ranked among companies with meaningful Current Ratio only.
ABMD' s 10-Year Current Ratio Range
Min: 3.67  Med: 5.46 Max: 14.38
Current: 5.6
3.67
14.38
Quick Ratio 5.17
ABMD's Quick Ratio is ranked higher than
81% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. ABMD: 5.17 )
Ranked among companies with meaningful Quick Ratio only.
ABMD' s 10-Year Quick Ratio Range
Min: 2.78  Med: 4.97 Max: 13.94
Current: 5.17
2.78
13.94
Days Inventory 134.38
ABMD's Days Inventory is ranked lower than
51% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 131.01 vs. ABMD: 134.38 )
Ranked among companies with meaningful Days Inventory only.
ABMD' s 10-Year Days Inventory Range
Min: 128.06  Med: 157.59 Max: 314.91
Current: 134.38
128.06
314.91
Days Sales Outstanding 50.44
ABMD's Days Sales Outstanding is ranked higher than
77% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.21 vs. ABMD: 50.44 )
Ranked among companies with meaningful Days Sales Outstanding only.
ABMD' s 10-Year Days Sales Outstanding Range
Min: 48.41  Med: 80.29 Max: 160.07
Current: 50.44
48.41
160.07

Valuation & Return

vs
industry
vs
history
Price/Net Cash 36.71
ABMD's Price/Net Cash is ranked lower than
78% of the 105 Companies
in the Global Medical Devices industry.

( Industry Median: 14.23 vs. ABMD: 36.71 )
Ranked among companies with meaningful Price/Net Cash only.
ABMD' s 10-Year Price/Net Cash Range
Min: 1.71  Med: 10.68 Max: 34.75
Current: 36.71
1.71
34.75
Price/Net Current Asset Value 18.05
ABMD's Price/Net Current Asset Value is ranked lower than
80% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 6.53 vs. ABMD: 18.05 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ABMD' s 10-Year Price/Net Current Asset Value Range
Min: 1.44  Med: 5.88 Max: 17.08
Current: 18.05
1.44
17.08
Price/Tangible Book 12.75
ABMD's Price/Tangible Book is ranked lower than
81% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. ABMD: 12.75 )
Ranked among companies with meaningful Price/Tangible Book only.
ABMD' s 10-Year Price/Tangible Book Range
Min: 1.34  Med: 5.37 Max: 12.07
Current: 12.75
1.34
12.07
Price/Projected FCF 8.02
ABMD's Price/Projected FCF is ranked lower than
83% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. ABMD: 8.02 )
Ranked among companies with meaningful Price/Projected FCF only.
ABMD' s 10-Year Price/Projected FCF Range
Min: 6.51  Med: 14.78 Max: 37.34
Current: 8.02
6.51
37.34
Price/Median PS Value 2.29
ABMD's Price/Median PS Value is ranked lower than
87% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 1.14 vs. ABMD: 2.29 )
Ranked among companies with meaningful Price/Median PS Value only.
ABMD' s 10-Year Price/Median PS Value Range
Min: 0.38  Med: 1.00 Max: 2.31
Current: 2.29
0.38
2.31
Price/Graham Number 3.95
ABMD's Price/Graham Number is ranked lower than
68% of the 136 Companies
in the Global Medical Devices industry.

( Industry Median: 2.46 vs. ABMD: 3.95 )
Ranked among companies with meaningful Price/Graham Number only.
ABMD' s 10-Year Price/Graham Number Range
Min: 3.74  Med: 5.77 Max: 15.85
Current: 3.95
3.74
15.85
Earnings Yield (Greenblatt) (%) 0.94
ABMD's Earnings Yield (Greenblatt) (%) is ranked higher than
52% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. ABMD: 0.94 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ABMD' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.1  Med: 1.05 Max: 3.7
Current: 0.94
0.1
3.7

Analyst Estimate

Mar16 Mar17 Mar18
Revenue(Mil) 292 362 448
EPS($) 0.44 0.92 1.30
EPS without NRI($) 0.44 0.92 1.30

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:AIO.Germany,
Abiomed Inc is a Delaware corporation incorporated on June 4, 1987. The Company is engaged in providing mechanical circulatory support devices and it offers a continuum of care in heart recovery to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. Its products are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. The Companys product portfolio includes; Impella 2.5, Impella CP, Impella RP, AB5000, Symphony, and Impella 5.0 & Impella LD. The Companys Impella 2.5 catheter is a percutaneous micro heart pump with an integrated motor and sensors for use mainly in interventional cardiology. The device is designed for use by interventional cardiologists to support patients in the cath lab who may require assistance to maintain their circulation. The Impella 5.0 catheter and Impella LD are percutaneous micro heart pumps with integrated motors and sensors for use mainly in the heart surgery suite. These devices are designed to support patients who require higher levels of circulatory support as compared to the Impella 2.5. The Impella RP is a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute and to provide the flow and pressure needed to compensate for right heart failure. The Company manufactures & sells the AB5000 Circulatory Support System for the temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. The Company faces competition from Getinge (Maquet Cardiovascular), Teleflex Inc., Thoratec Corporation, HeartWare International Inc., Jarvik Heart, Terumo Heart, Inc. and CardiacAssist Inc. The Companys business is subject to extensive federal, state, local and foreign regulation.
» More Articles for ABMD

Headlines

Articles On GuruFocus.com
Impressive Numbers That Matter: Abiomed Inc (ABMD), Freescale Semiconductor Ltd (FSL), Apple Inc (AA Jan 28 2015 
Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 
Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 
Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX Jul 17 2012 
ABIOMED Inc. Reports Operating Results (10-Q) Feb 04 2011 
ABIOMED Inc. Reports Operating Results (10-Q) Aug 05 2010 
ABIOMED Inc. (ABMD) COO David M Weber sells 1,389 Shares May 25 2010 
ABIOMED Inc. (ABMD) President, CEO, Chairman Michael R Minogue sells 4,491 Shares May 25 2010 
Trade Setups for May 19, 2010 May 19 2010 

More From Other Websites
Something For Everyone: 4 Top Stocks In Buy Range Jul 30 2015
Abiomed Close To New Buy Point Ahead Of Q1 Earnings Jul 29 2015
Abiomed First Quarter Fiscal 2016 Earnings and Conference Call Notification Jul 29 2015
Converging On A Heartthrob Market Jul 24 2015
Breakout Watch: Abiomed Pumps Up Before Earnings Jul 23 2015
Breakout Watch: Abiomed Pumps Up Before Q2 Earnings Jul 23 2015
Stock Market Today - 07/21/15 Jul 21 2015
Top Stock Abiomed Nears Buy Point Ahead Of Earnings Jul 17 2015
Abiomed First Quarter Fiscal 2016 Earnings and Conference Call Notification Jul 14 2015
12 market-beating stocks from a 214-year-old strategy Jul 10 2015
Top Mutual Funds Add Abiomed, Tech Stocks And Monster Jul 07 2015
Abiomed Breathes Easy as DOJ Ends Impella Suite Probe - Analyst Blog Jul 02 2015
ABIOMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 29 2015
United States Department of Justice Closes Investigation Into Abiomed's Impella 2.5 Jun 29 2015
United States Department of Justice Closes Investigation Into Abiomed’s Impella 2.5 Jun 29 2015
ABIOMED INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 19 2015
Abiomed Looks to Expand, Add New Jobs and Infrastructure - Analyst Blog Jun 17 2015
Abiomed to expand headquarters and hire 100 workers in Danvers Jun 16 2015
Abiomed to Present at the William Blair Growth Stock Conference Jun 04 2015
Abiomed to Present at the William Blair Growth Stock Conference Jun 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK